NXP081, DNA Aptamer–Vitamin C Complex Ameliorates DNFB-Induced Atopic Dermatitis in Balb/c Mice
Nutrients · 2023
DOI: 10.3390/nu15194172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Sanggon Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Aptamers, Nucleotide, Skin Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was fully supported by the Nexmos Co., Ltd., Republic of Korea., Nexmos Co., Ltd., Republic of Korea.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory disease characterized by dry and itchy skin. Recently, it has been reported that oxidative stress is involved in skin diseases, possibly including AD. Vitamin C, also referred to as ascorbic acid, is a vital water-soluble compound that functions as an essential nutrient. It plays a significant role as both an antioxidant and an additive in various pharmaceutical and food products. Despite the fact that vitamin C is easily oxidized, we have developed NXP081, a single-stranded DNA aptamer that selectively binds to vitamin C, thereby inhibiting its oxidation. The objective of the current research was to examine the impact of NXP081, an animal model of AD induced by 2,4-dinitrofluorobenzene (DNFB). The experimental drug NXP081, when taken orally, showed promising results in reducing inflammation and improving the skin conditions caused by DNFB. The administration of NXP081 resulted in a significant reduction in ear swelling and a noticeable improvement in the appearance of skin lesions. In addition, the administration of NXP081 resulted in a significant decrease in the migration of mast cells in the skin lesions induced by DNFB. Moreover, NXP081 inhibited the production of interferon-gamma (IFN-γ) in CD4+ T cells that were activated and derived from the lymph nodes. Our findings provide useful information about the anti-inflammatory effect of NXP081 on AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Nexmos Co., Ltd., U-Tower, 767, Sinsu-ro, Yongin-si 16827, Republic of Korea.
ORCID-Profile: Yong Seek Park
Förderung
- This work was fully supported by the Nexmos Co., Ltd., Republic of Korea.
- Nexmos Co., Ltd., Republic of Korea
Zitieren
APA
Lee, S., Ahn, H. J., Park, Y. S., Kim, J. H., Kim, Y. S., Cho, J. J., & Park, C. S. (2023). NXP081, DNA Aptamer–Vitamin C Complex Ameliorates DNFB-Induced Atopic Dermatitis in Balb/c Mice. Nutrients. https://doi.org/10.3390/nu15194172
Vancouver
Lee S, Ahn HJ, Park YS, Kim JH, Kim YS, Cho JJ, et al. NXP081, DNA Aptamer–Vitamin C Complex Ameliorates DNFB-Induced Atopic Dermatitis in Balb/c Mice. Nutrients. 2023. doi:10.3390/nu15194172
BibTeX
@article{Lee2023,
author = {Lee, Sanggon and Ahn, Hyun-Jong and Park, Yong Seek and Kim, Ji-Hyun and Kim, Yoon-Seong and Cho, Jeong-Je and Park, Cheung-Seog},
title = {NXP081, DNA Aptamer–Vitamin C Complex Ameliorates DNFB-Induced Atopic Dermatitis in Balb/c Mice},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15194172}
}
EUVIMED